Developing a novel industrial enzyme can take years and cost millions, with high failure rates. The process is bottlenecked by:
- Low-throughput screening: Testing thousands of physical variants is slow.
- Limited search space: Manual design explores a tiny fraction of possible sequences.
- Unpredictable performance: Small mutations can drastically alter stability and activity.




